Maximilian Pistor

5PUBLICATIONS
12CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersMotor controlAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 08, 2026
Mitigating the Impact of MR Sequence Parameters: Increasing the Robustness of DL-Based Cortical Thickness Estimates.

|Oct 14, 2022
Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System.

Maximilian Pistor, Robert Hoepner, Andreas G F Hoepner

|Jan 21, 2022
Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort.

Maximilian Pistor, Helly Hammer, Anke Salmen

|Jul 21, 2021
Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System.

Maximilian Pistor, Andreas G F Hoepner, Yanan Lin

|Sep 26, 2020
c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis.

Maud Bagnoud, Myriam Briner, Jana Remlinger

Pageof 1

Frequent Collaborators

4 joint publications

Anke Salmen

3 joint publications

Robert Hoepner

1 joint publications

Helly Hammer

1 joint publications

Christoph Friedli